Skip to content

Stem Cell

Page 1 of 2

A Harvard research team led by Kevin Kit Parker, a Harvard Stem Cell Institute principal faculty member, has identified a set of 64 crucial parameters by which to judge stem cell-derived cardiac myocytes, making it possible for scientists and pharmaceutical companies to quantitatively judge and compare the value of stem cells.

Quality control

Harvard researchers develop long-needed standards for gauging ‘good’ stem cells



On the left are normal endothelial cells, while those on the right have been reprogrammed into cells nearly identical to adult stem cells, hence the morphological distinctions.

Rare find

Study of genetic disease reveals new path to cell reprogramming